322 related articles for article (PubMed ID: 11362921)
61. FDA expands testing of anti-AIDS drugs.
N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
[No Abstract] [Full Text] [Related]
62. The Delta trial.
Zaretsky MD
Lancet; 1997 Feb; 349(9048):358-9. PubMed ID: 9024402
[No Abstract] [Full Text] [Related]
63. IL-2 restores immune sytem.
Grodeck B
Posit Aware; 1995; ():8. PubMed ID: 11362384
[TBL] [Abstract][Full Text] [Related]
64. Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Fleming TR; Neaton JD; Goldman A; DeMets DL; Launer C; Korvick J; Abrams D
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S9-18. PubMed ID: 7552519
[TBL] [Abstract][Full Text] [Related]
65. Nevirapine triple combo results released.
Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362346
[TBL] [Abstract][Full Text] [Related]
66. Eradication of HIV: the cutting edge of clinical trial design.
Crit Path AIDS Proj; 1996; (No 31):16-7. PubMed ID: 11363825
[TBL] [Abstract][Full Text] [Related]
67. [Anti-HIV-therapy. Monotherapy with drugs delaying the course of the disease has limited effect].
Julander I; Britton S
Lakartidningen; 1994 Jul; 91(30-31):2759, 2762-3. PubMed ID: 7520104
[No Abstract] [Full Text] [Related]
68. Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy.
Hoth D
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S95-6. PubMed ID: 2172506
[No Abstract] [Full Text] [Related]
69. Lamivudine (3TC) approved for combination use with AZT.
James JS
AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
[TBL] [Abstract][Full Text] [Related]
70. Clinicians experiment with post-exposure drug pairs.
AIDS Alert; 1996 Feb; 11(2):16-7. PubMed ID: 11363233
[TBL] [Abstract][Full Text] [Related]
71. Combination antiretroviral treatment: new views, evolving practices.
James JS
AIDS Treat News; 1995 Jul; (no 226):1-2. PubMed ID: 11362612
[TBL] [Abstract][Full Text] [Related]
72. Drug companies seek trial participants.
AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
[TBL] [Abstract][Full Text] [Related]
73. 3TC approved: now for the tough questions.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):6-8. PubMed ID: 11363101
[TBL] [Abstract][Full Text] [Related]
74. Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.
Graham NM; Hoover DR; Park LP; Stein DS; Phair JP; Mellors JW; Detels R; Saah AJ
Ann Intern Med; 1996 Jun; 124(12):1031-8. PubMed ID: 8633816
[TBL] [Abstract][Full Text] [Related]
75. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.
Domanski MJ; Sloas MM; Follmann DA; Scalise PP; Tucker EE; Egan D; Pizzo PA
J Pediatr; 1995 Jul; 127(1):137-46. PubMed ID: 7608800
[TBL] [Abstract][Full Text] [Related]
76. Combining d4T/ddI looks promising.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
[TBL] [Abstract][Full Text] [Related]
77. Merck protease inhibitor: more news from Retroviruses Conference.
James JS
AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
[TBL] [Abstract][Full Text] [Related]
78. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial.
Kastrissios H; Suárez JR; Katzenstein D; Girard P; Sheiner LB; Blaschke TF
AIDS; 1998 Dec; 12(17):2295-303. PubMed ID: 9863872
[TBL] [Abstract][Full Text] [Related]
79. Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
Bray JM
STEP Perspect; 1995; 7(3):10-1. PubMed ID: 11362980
[TBL] [Abstract][Full Text] [Related]
80. Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
Mathe G; Morette C; Hallard M; Pontiggia P; Blanquet D; Hage F
Acta Pharmacol Sin; 2002 Jan; 23(1):1-15. PubMed ID: 11860730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
